Ol'GA V. Dashkevich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ol'GA V. Dashkevich has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Ekaterina I. Suchkova
Pavlov Ryazan State Medical University
4 shared publications - Nailya Sayfullaevna Asfandiyarova
I.P. Pavlov Ryazan State Medical University, Ministry of Health of Russia
4 shared publications - Natalia V. Doroshina
Ryazan State Medical University
2 shared publications Асфандиярова Наиля Сайфуллаевна
Рязанский государственный медицинский университет имени академика И.П. Павлова
2 shared publications- A. A. Nizov
Ryazan State Medical University named after academician I.P. Pavlov
1 shared publication - A. N. Yakubenko
City polyclinic № 6
1 shared publication
Latest Publications
- Open Access
- 15 October 2022
- Published by Publishing House ABV Press in The Clinician
- Vol. 16 (4) , 19-26
Risk factors for development of the post-COVID syndrome
Aim: to study risk factors of development of the post-COVID syndrome (PCS).Material and methods. 210 patients with a history of new coronavirus infection (COVID-19) (47 men, 163 women aged 18–85 years) were examined by doctors of various specialties. Patients were divided into several groups depending on the presence of PCS, as well as the severity of the disease.Results. The risk factors of the PCS development are moderate and severe course of the pathological process in acute period of COVID-19 disease (p 0.001). In women, PCS is seen more often than in men (30 / 135 vs. 17 / 28, p 0 / 001), other risk factors are age over 50 years (p 0.05), polymorbidity (p 0.01), treatment with glucocorticoids in acute disease period (76 / 165 vs. 4 / 45, p 0.001). In cases of mild COVID-19 course, neither age nor polymorbidity increased the risk of PCS development (p 0.05), however a dysfunction of cellular immunity was significant, specifically the proliferative activity of lymphocytes in response to mitogen: 50.6 ± 10.4 % vs. 54.0 ± 5.1 %, p 0.05). In cases of severe COVID-19 course, the gender differences and dysfunction of the cellular immune system are not the determinants for the PCS development (p 0.05), however the age (56.7 ± 13.1 years vs. 42.1 ± 15.4 years, p 0.01) its linkage to somatic pathology (a cardiovascular disease) besides glucocorticoids threatment (64 / 89 vs. 3 / 9, p 0.05) are important risk factors for PCS.Conclusions. The main risk factor for PCS development is the moderate and severe course of the pathological process in the acute period of COVID-19 infection, female gender, age over 50 years, polymorbidity, treatment with glucocorticoids in the disease acute period. In case of mild COVID-19 course, neither age nor the polymorbidity increased the risk of PCS development, but the dysfunction of cellular immunity is significant. In case of severe COVID-19, the gender differences and dysfunction of the cellular immune system are not the determinants for the PCS development, however age, concomitant somatic pathology (a cardiovascular disease) and glucocorticoids treatment in acute period are important risk factors for the PCS development. The titer of protective IgG class antibodies to SARS-CoV-2 is not linked to risk of the PCS development.
- 15 October 2022
- Published by Publishing House ABV Press in The Clinician
- Vol. 16 (4) , 19-26
Open AccessRisk factors for development of the post-COVID syndrome
Aim: to study risk factors of development of the post-COVID syndrome (PCS).Material and methods. 210 patients with a history of new coronavirus infection (COVID-19) (47 men, 163 women aged 18–85 years) were examined by doctors of various specialties. Patients were divided into several groups depending on the presence of PCS, as well as the severity of the disease.Results. The risk factors of the PCS development are moderate and severe course of the pathological process in acute period of COVID-19 disease (p 0.001). In women, PCS is seen more often than in men (30 / 135 vs. 17 / 28, p 0 / 001), other risk factors are age over 50 years (p 0.05), polymorbidity (p 0.01), treatment with glucocorticoids in acute disease period (76 / 165 vs. 4 / 45, p 0.001). In cases of mild COVID-19 course, neither age nor polymorbidity increased the risk of PCS development (p 0.05), however a dysfunction of cellular immunity was significant, specifically the proliferative activity of lymphocytes in response to mitogen: 50.6 ± 10.4 % vs. 54.0 ± 5.1 %, p 0.05). In cases of severe COVID-19 course, the gender differences and dysfunction of the cellular immune system are not the determinants for the PCS development (p 0.05), however the age (56.7 ± 13.1 years vs. 42.1 ± 15.4 years, p 0.01) its linkage to somatic pathology (a cardiovascular disease) besides glucocorticoids threatment (64 / 89 vs. 3 / 9, p 0.05) are important risk factors for PCS.Conclusions. The main risk factor for PCS development is the moderate and severe course of the pathological process in the acute period of COVID-19 infection, female gender, age over 50 years, polymorbidity, treatment with glucocorticoids in the disease acute period. In case of mild COVID-19 course, neither age nor the polymorbidity increased the risk of PCS development, but the dysfunction of cellular immunity is significant. In case of severe COVID-19, the gender differences and dysfunction of the cellular immune system are not the determinants for the PCS development, however age, concomitant somatic pathology (a cardiovascular disease) and glucocorticoids treatment in acute period are important risk factors for the PCS development. The titer of protective IgG class antibodies to SARS-CoV-2 is not linked to risk of the PCS development.
- 6 October 2021
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 29 (3) , 364-368
Advantages and disadvantages of lockdown (self-isolation regime) introduced during the first wave of coronaviral infection for patients with polymorbid pathology
AIM: To study the structure of mortality not caused by coronavirus infection, in patients with polymorbid pathology during the period of self-isolation (lockdown). MATERIALS AND METHODS: Outpatient records of 2 423 patients with polymorbid pathology (841 males and 1 582 females, aged from 18 to 99 years) were examined. The mortality and its causes during three years including a period of lockdown were investigated. RESULTS: The overall mortality rate among patients with polymorbid pathology was 10.2% without differences in gender. The structure of the causes of death in patients with polymorbidity: cardiovascular diseases accounted for 50.8%, oncological diseases 21%, nervous system diseases 7.3%. During the lockdown, an increase in overall mortality by 34.3% was recorded (p 0.05), with an increase in the number of deaths of patients with cardiovascular diseases by 19.5% (p 0.05) (mostly patients with ischemic heart disease). CONCLUSION: An increase in the number of deceased patients with polymorbidity during the lockdown may be due to the limitation of physical activity, of the possibility of examination and consultation by profile specialists. Taking into account the vulnerability of this group of patients, there is an urgent need to develop preventive measures when the situation recurs.
- 6 October 2021
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 29 (3) , 364-368
Advantages and disadvantages of lockdown (self-isolation regime) introduced during the first wave of coronaviral infection for patients with polymorbid pathology
AIM: To study the structure of mortality not caused by coronavirus infection, in patients with polymorbid pathology during the period of self-isolation (lockdown). MATERIALS AND METHODS: Outpatient records of 2 423 patients with polymorbid pathology (841 males and 1 582 females, aged from 18 to 99 years) were examined. The mortality and its causes during three years including a period of lockdown were investigated. RESULTS: The overall mortality rate among patients with polymorbid pathology was 10.2% without differences in gender. The structure of the causes of death in patients with polymorbidity: cardiovascular diseases accounted for 50.8%, oncological diseases 21%, nervous system diseases 7.3%. During the lockdown, an increase in overall mortality by 34.3% was recorded (p 0.05), with an increase in the number of deaths of patients with cardiovascular diseases by 19.5% (p 0.05) (mostly patients with ischemic heart disease). CONCLUSION: An increase in the number of deceased patients with polymorbidity during the lockdown may be due to the limitation of physical activity, of the possibility of examination and consultation by profile specialists. Taking into account the vulnerability of this group of patients, there is an urgent need to develop preventive measures when the situation recurs.
- Open Access
- 17 April 2019
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 18 (2) , 70-75
Cardiovascular comorbidity in the real clinical practice of an ambulatory physician. Comparative register research in the Ryazan region
Кардиоваскулярная коморбидность в реальной клинической практике амбулаторного врача. Сравнительное регистровое исследование в Рязанской области
- 17 April 2019
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 18 (2) , 70-75
Open AccessCardiovascular comorbidity in the real clinical practice of an ambulatory physician. Comparative register research in the Ryazan region
Кардиоваскулярная коморбидность в реальной клинической практике амбулаторного врача. Сравнительное регистровое исследование в Рязанской области
- Open Access
- 29 December 2018
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 21 (6) , 455-461
Type 2 diabetes mellitus and multiple chronic diseases
Background: Recently, there has been an increase in the number of patients with multiple chronic diseases (MCD), particularly due to obesity and ageing. The role of type 2 diabetes mellitus (T2DM) in the development of MCD, however, is still unclear. Aims: This study aimed to determine the incidence of T2DM in the structure of polymorbidity considering sex and age-related characteristics. Materials and methods: Patients with MCD (n = 2,254; 769 men/1,485 women; aged, 1899 years) were examined. The incidence of type 2 diabetes among patients with MCD considering age and sex was determined. Results: Type 2 DM was detected in 407 patients with MCD (18.1%; male:female, 1:2.53). The polymorbidity index in male patients with type 2 diabetes was 1.52.0 times higher than that in male patients without diabetes. The rate of polymorbidity index increase was similar in both groups; however, its high initial value in patients with diabetes at a young age determined the burden of the comorbidity at a later age. In type 2 diabetes, hypertension was the predominant comorbidity at 1859 years of age (p0.05), whereas other cardiovascular diseases and liver and kidney diseases were predominant at 4574 years of age (p0.001) and hemiplegia at 4589 years of age (p0.05). Between 60 and 74 years, oncological diseases were found to be more common in patients without diabetes (p0.001). Obesity, regardless of the presence of diabetes, was associated with a greater disease burden (p0.05). Sex-related difference considering MCD in patients with type 2 DM was only observed for the higher incidence of myocardial infarction (p0.001) and peptic ulcer disease in males (p0.01). Females were more likely to have obesity, liver steatosis at a young age, or osteoarthritis than males in the general group (p0.05); no differences were noted with respect to other diseases. Conclusions: In this study, type 2 diabetes was present in 18.1% of patients with MCD; moreover, a high initial polymorbidity index in patients with T2DM at young age was associated with a higher incidence of chronic diseases later in life than that in patients without diabetes. Based on these results, type 2 diabetes, along with ageing and obesity, can be considered as a risk factor in the development of MCD.
- 29 December 2018
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 21 (6) , 455-461
Open AccessType 2 diabetes mellitus and multiple chronic diseases
Background: Recently, there has been an increase in the number of patients with multiple chronic diseases (MCD), particularly due to obesity and ageing. The role of type 2 diabetes mellitus (T2DM) in the development of MCD, however, is still unclear. Aims: This study aimed to determine the incidence of T2DM in the structure of polymorbidity considering sex and age-related characteristics. Materials and methods: Patients with MCD (n = 2,254; 769 men/1,485 women; aged, 1899 years) were examined. The incidence of type 2 diabetes among patients with MCD considering age and sex was determined. Results: Type 2 DM was detected in 407 patients with MCD (18.1%; male:female, 1:2.53). The polymorbidity index in male patients with type 2 diabetes was 1.52.0 times higher than that in male patients without diabetes. The rate of polymorbidity index increase was similar in both groups; however, its high initial value in patients with diabetes at a young age determined the burden of the comorbidity at a later age. In type 2 diabetes, hypertension was the predominant comorbidity at 1859 years of age (p0.05), whereas other cardiovascular diseases and liver and kidney diseases were predominant at 4574 years of age (p0.001) and hemiplegia at 4589 years of age (p0.05). Between 60 and 74 years, oncological diseases were found to be more common in patients without diabetes (p0.001). Obesity, regardless of the presence of diabetes, was associated with a greater disease burden (p0.05). Sex-related difference considering MCD in patients with type 2 DM was only observed for the higher incidence of myocardial infarction (p0.001) and peptic ulcer disease in males (p0.01). Females were more likely to have obesity, liver steatosis at a young age, or osteoarthritis than males in the general group (p0.05); no differences were noted with respect to other diseases. Conclusions: In this study, type 2 diabetes was present in 18.1% of patients with MCD; moreover, a high initial polymorbidity index in patients with T2DM at young age was associated with a higher incidence of chronic diseases later in life than that in patients without diabetes. Based on these results, type 2 diabetes, along with ageing and obesity, can be considered as a risk factor in the development of MCD.
- Open Access
- 15 October 2017
- Published by Publishing House ABV Press in The Clinician
- Vol. 11 (3-4) , 65-72
GENDER AND AGE STRUCTURE OF MULTIPLE CHRONIC DISEASES IN PATIENTS OF RYAZAN REGION
The study objective is to investigate gender and age structure of multiple chronic conditions (MCC) among patients seeking medical help from a primary care physician.Materials and methods. In total, 1940 patients under the care of primary care physicians in several polyclinics of Ryazan and the Ryazan Region were examined: 646 men and 1294 women aged 18–99. The list of conditions included cardiovascular disorders, lung, gastrointestinal, kidney diseases, oncological diseases, diabetes mellitus, etc. All diagnoses were made per the generally accepted criteria. The patients were divided into 5 age groups; age and gender structure of MCC, as well as polymorbidity index (total number of conditions per 1 patient), were determined.Results. Among all patients with MCC in all age groups, the number of women was larger than men. In the structure of MCC, predominance of cardiovascular disorders, diseases of the kidneys and joints was observed. With age, the fraction of patients in whom the majority of organs and systems was affected increased. However, in older patients, peptic ulcer disease, diabetes mellitus, oncological and autoimmune diseases were comparatively rare. In men, the mean number of diseases per 1 patient was higher, but after 75 years of age the number of conditions in women exceeded the number in men. In obese patients, age increase led to quicker polymorbidity increase than in normal patients. The gender differences consisted of the prevalence of stomach/duodenal peptic ulcer, non-specific lung diseases, obliterating atherosclerosis of the lower extremities in men, and kidney diseases, diabetes mellitus type 2 in women.Conclusion. The main causes of polymorbidity are old age and obesity. In the structure of MCC, cardiovascular diseases, kidney and joint disorders are the most common. A gender difference in the incidence of some diseases is observed.
- 15 October 2017
- Published by Publishing House ABV Press in The Clinician
- Vol. 11 (3-4) , 65-72
Open AccessGENDER AND AGE STRUCTURE OF MULTIPLE CHRONIC DISEASES IN PATIENTS OF RYAZAN REGION
The study objective is to investigate gender and age structure of multiple chronic conditions (MCC) among patients seeking medical help from a primary care physician.Materials and methods. In total, 1940 patients under the care of primary care physicians in several polyclinics of Ryazan and the Ryazan Region were examined: 646 men and 1294 women aged 18–99. The list of conditions included cardiovascular disorders, lung, gastrointestinal, kidney diseases, oncological diseases, diabetes mellitus, etc. All diagnoses were made per the generally accepted criteria. The patients were divided into 5 age groups; age and gender structure of MCC, as well as polymorbidity index (total number of conditions per 1 patient), were determined.Results. Among all patients with MCC in all age groups, the number of women was larger than men. In the structure of MCC, predominance of cardiovascular disorders, diseases of the kidneys and joints was observed. With age, the fraction of patients in whom the majority of organs and systems was affected increased. However, in older patients, peptic ulcer disease, diabetes mellitus, oncological and autoimmune diseases were comparatively rare. In men, the mean number of diseases per 1 patient was higher, but after 75 years of age the number of conditions in women exceeded the number in men. In obese patients, age increase led to quicker polymorbidity increase than in normal patients. The gender differences consisted of the prevalence of stomach/duodenal peptic ulcer, non-specific lung diseases, obliterating atherosclerosis of the lower extremities in men, and kidney diseases, diabetes mellitus type 2 in women.Conclusion. The main causes of polymorbidity are old age and obesity. In the structure of MCC, cardiovascular diseases, kidney and joint disorders are the most common. A gender difference in the incidence of some diseases is observed.